Skip to main content
Fig. 4 | Journal of Experimental & Clinical Cancer Research

Fig. 4

From: The epigenetically downregulated factor CYGB suppresses breast cancer through inhibition of glucose metabolism

Fig. 4

Expression proteomic and metabolomic analyses of CYGB overexpression in MCF7 cells. a Enrichment of differentially-expressed proteins categorized by function. b KEGG Pathway analysis revealed the expression of proteins involved in multiple metabolism pathways, including glycolysis/gluconeogenesis, are widely altered by CYGB. c and d Pathway analysis of differential metabolites identified by gas chromatography-mass spectrometry metabolomics assay. Data was analyzed using MetaboAnalyst software

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us